Novo Nordisk’s Buyback Blitz Masks Building Pressure Ahead of 2027 Price Cuts
The Danish pharmaceutical heavyweight is buying back shares at a record pace, yet the same weekly disclosures that…
Novo Nordisk Forges Ahead with Oral Wegovy and Weekly Insulin Amid CagriSema Device Study Withdrawal
Novo Nordisk is executing a multi-front strategy to defend its dominance in the obesity and diabetes markets, rolling…
With 40,000 Departures Ahead, Berlin Overhauls Staff Representation to Attract Talent
With, Departures
24.06.2026 – 05:23:20 | boerse-global.de
Berlin Senate approves rewrite of staff…
Berlin Schools Bleed 2,668 Teachers as German Court Puts Public Duty Ahead of Private Wants
A recent administrative court ruling in Gelsenkirchen highlights the mounting tension between personal convenience and the urgent need…
Novo Nordisk at a Crossroads: Pipeline Hopes Meet Pricing Pressures Ahead of ADA and Medicare Shift
New semaglutide kidney data boosts pipeline confidence, but CVS formulary changes and discounted Medicare pricing pressure margins, sending…
Novo Nordisk’s Oral Wegovy Attracts 80% New Patients Ahead of EU Rollout
Nearly 80% of Wegovy pill users are new to GLP-1 drugs, easing cannibalization fears. EU recommends oral 25…
Coalition of major European Union countries push for tougher China policy ahead of Brussels debate
Agencies Brussels A coalition of major EU member states is pushing Brussels towards a much tougher trade regime…